BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15059844)

  • 1. Individualized risks of first adverse events in patients with Fanconi anemia.
    Rosenberg PS; Huang Y; Alter BP
    Blood; 2004 Jul; 104(2):350-5. PubMed ID: 15059844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
    Rosenberg PS; Alter BP; Ebell W
    Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer incidence in persons with Fanconi anemia.
    Rosenberg PS; Greene MH; Alter BP
    Blood; 2003 Feb; 101(3):822-6. PubMed ID: 12393424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preemptive Bone Marrow Transplantation and Event-Free Survival in Fanconi Anemia.
    Khan NE; Rosenberg PS; Alter BP
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1888-1892. PubMed ID: 27345141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
    Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
    Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis on phenotype and genetic basis of Chinese Fanconi anemia patients: dismal outcomes call for nationwide studies.
    Nie D; Zhang J; Wang F; Zhang W; Liu L; Chen X; Zhang Y; Cao P; Xiong M; Wang T; Wu P; Ma X; Tian W; Wang M; Chen KN; Liu H
    BMC Med Genet; 2020 Jun; 21(1):118. PubMed ID: 32487094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 20-year perspective on the International Fanconi Anemia Registry (IFAR).
    Kutler DI; Singh B; Satagopan J; Batish SD; Berwick M; Giampietro PF; Hanenberg H; Auerbach AD
    Blood; 2003 Feb; 101(4):1249-56. PubMed ID: 12393516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi anaemia: A syndrome with distinct subgroups.
    Alter BP; Giri N; McReynolds LJ; Altintas B
    Br J Haematol; 2022 May; 197(4):467-474. PubMed ID: 35191533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype and outcome associations in patients with Fanconi anemia: the National Cancer Institute cohort.
    Altintas B; Giri N; McReynolds LJ; Best A; Alter BP
    Haematologica; 2023 Jan; 108(1):69-82. PubMed ID: 35417938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fanconi anemia and the development of leukemia.
    Alter BP
    Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry.
    Auerbach AD; Allen RG
    Cancer Genet Cytogenet; 1991 Jan; 51(1):1-12. PubMed ID: 1984836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Fanconi anemia in children with congenital thumb anomalies referred for diepoxybutane testing.
    Webb ML; Rosen H; Taghinia A; McCarty ER; Cerrato F; Upton J; Labow BI
    J Hand Surg Am; 2011 Jun; 36(6):1052-7. PubMed ID: 21514743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple synchronous tumors in a child with Fanconi anemia.
    Compostella A; Toffolutti T; Soloni P; Dall'Igna P; Carli M; Bisogno G
    J Pediatr Surg; 2010 Feb; 45(2):e5-8. PubMed ID: 20152336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic changes during progression from Fanconi anemia into acute myeloid leukemia: case report and brief review of the literature.
    Vélez-Ruelas MA; Martínez-Jaramillo G; Arana-Trejo RM; Mayani H
    Hematology; 2006 Oct; 11(5):331-4. PubMed ID: 17607582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fanconi anemia: a single center experience of a large cohort.
    Kesici S; Ünal Ş; Kuşkonmaz B; Aytaç S; Çetin M; Gümrük F
    Turk J Pediatr; 2019; 61(4):477-484. PubMed ID: 31990462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer in Fanconi anemia, 1927-2001.
    Alter BP
    Cancer; 2003 Jan; 97(2):425-40. PubMed ID: 12518367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients.
    Lecourt S; Vanneaux V; Leblanc T; Leroux G; Ternaux B; Benbunan M; Chomienne C; Baruchel A; Marolleau JP; Gluckman E; Socié G; Soulier J; Larghero J
    Stem Cells Dev; 2010 Feb; 19(2):203-8. PubMed ID: 19572808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
    Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
    Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of malignancy and clonal chromosomal abnormalities in Fanconi anemia.
    Vundinti BR; Korgaonkar S; Ghosh K
    Indian J Cancer; 2010; 47(4):397-9. PubMed ID: 21131752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How I treat MDS and AML in Fanconi anemia.
    Peffault de Latour R; Soulier J
    Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.